Ozes O N, Mayo L D, Gustin J A, Pfeffer S R, Pfeffer L M, Donner D B
Department of Microbiology and Immunology, Indiana University School of Medicine, the Walther Oncology Center, Indianapolis 46202, USA.
Nature. 1999 Sep 2;401(6748):82-5. doi: 10.1038/43466.
Activation of the nuclear transcription factor NF-kappaB by inflammatory cytokines requires the successive action of NF-kappaB-inducing kinase (NIK) and an IKB-kinase (IKK) complex composed of IKKalpha and IKKbeta. Here we show that the Akt serine-threonine kinase is involved in the activation of NF-kappaB by tumour necrosis factor (TNF). TNF activates phosphatidylinositol-3-OH kinase (PI(3)K) and its downstream target Akt (protein kinase B). Wortmannin (a PI(3)K inhibitor), dominant-negative PI(3)K or kinase-dead Akt inhibits TNF-mediated NF-kappaB activation. Constitutively active Akt induces NF-kappaB activity and this effect is blocked by dominant-negative NIK. Conversely, NIK activates NF-kappaB and this is blocked by kinase-dead Akt. Thus, both Akt and NIK are necessary for TNF activation of NF-kappaB. Akt mediates IKKalpha phosphorylation at threonine 23. Mutation of this amino acid blocks phosphorylation by Akt or TNF and activation of NF-kappaB. These findings indicate that Akt is part of a signalling pathway that is necessary for inducing key immune and inflammatory responses.
炎性细胞因子激活核转录因子NF-κB需要NF-κB诱导激酶(NIK)以及由IKKα和IKKβ组成的IκB激酶(IKK)复合物的相继作用。在此我们表明,Akt丝氨酸-苏氨酸激酶参与肿瘤坏死因子(TNF)对NF-κB的激活。TNF激活磷脂酰肌醇-3-OH激酶(PI(3)K)及其下游靶点Akt(蛋白激酶B)。渥曼青霉素(一种PI(3)K抑制剂)、显性负性PI(3)K或激酶失活的Akt可抑制TNF介导的NF-κB激活。组成型活性Akt诱导NF-κB活性,且这种效应被显性负性NIK阻断。相反,NIK激活NF-κB,且这被激酶失活的Akt阻断。因此,Akt和NIK对于TNF激活NF-κB均是必需的。Akt介导IKKα在苏氨酸23处的磷酸化。该氨基酸的突变阻断Akt或TNF介导的磷酸化以及NF-κB的激活。这些发现表明,Akt是诱导关键免疫和炎症反应所必需的信号通路的一部分。